On March 29, 2023, the FDA approved Narcan, a brand name of naloxone nasal spray used to immediately treat those experiencing an opioid overdose, for over-the-counter sale. The decision was made in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results